Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INIPARIB Cause Metastases to bone marrow? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Metastases to bone marrow have been filed in association with INIPARIB. This represents 27.8% of all adverse event reports for INIPARIB.

10
Reports of Metastases to bone marrow with INIPARIB
27.8%
of all INIPARIB reports
0
Deaths
10
Hospitalizations

How Dangerous Is Metastases to bone marrow From INIPARIB?

Of the 10 reports, 10 (100.0%) required hospitalization.

Is Metastases to bone marrow Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INIPARIB. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does INIPARIB Cause?

Anaemia (16) Thrombocytopenia (16) Malignant neoplasm progression (15) Disease progression (10) Invasive ductal breast carcinoma (10) Product use in unapproved indication (10) Bone marrow infiltration (6)

What Other Drugs Cause Metastases to bone marrow?

CYCLOPHOSPHAMIDE (65) DOXORUBICIN (40) CYTARABINE (36) CARBOPLATIN (35) ZOLEDRONIC ACID (32) ETOPOSIDE (31) OXALIPLATIN (30) RIBOCICLIB (29) RITUXIMAB (29) VINCRISTINE (28)

Related Pages

INIPARIB Full Profile All Metastases to bone marrow Reports All Drugs Causing Metastases to bone marrow INIPARIB Demographics